Adagio Medical Holdings Inc (ADGM) Stock Price, Quote & News

Company Profile

Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdin...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 348 1188

Website: adagiomedical.com

Address:

26051 Merit Circle, Suite 102, Laguna Hills, United States

SearchFor911 May. 7 at 11:16 AM

$ADGM very attractive risk/reward here

0 · Reply

BioTuesdays May. 5 at 3:17 PM

$ADGM is innovating catheter ablation technologies for the treatment of one of the most challenging and underserved areas in electrophysiology—ventricular tachycardia (VT), a dangerous type of cardiac arrhythmia that causes chest pain, fainting and sudden cardiac arrest. https://biotuesdays.com/2026/05/05/adagio-delivering-first-of-its-kind-innovation-in-cardiac-ablation-technology/

1 · Reply

87trades May. 5 at 1:48 PM

$ADGM https://biotuesdays.com/2026/05/05/adagio-delivering-first-of-its-kind-innovation-in-cardiac-ablation-technology/

2 · Reply

zacharyjay4934 May. 4 at 6:57 PM

$ADGM What do we think their intention is around participating?

1 · Reply

VenomSenses May. 2 at 11:52 AM

$ADGM low volume run monday real volume

0 · Reply

PLX_BULLS May. 1 at 12:56 PM

$ADGM Does anyone know the total mean ablation procedure time? Advent trial for pulse field ablation was 106 minutes.

1 · Reply

Rafa007 May. 1 at 11:52 AM

$ADGM teed???????

0 · Reply

PLX_BULLS May. 1 at 3:21 AM

$ADGM What’s their current cash on hand? Do they have a covenant for that 20m in debt?

1 · Reply

slevin_kelevra Apr. 30 at 8:38 PM

$ADGM ugly

0 · Reply

rmccarthy8 Apr. 30 at 12:48 PM

$ADGM why did the stock price plummet after strong data results?!?

2 · Reply

Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference

2026-04-26T17:30:32.000Z - 12 days ago

Adagio Medical reports six-month results from Fulcrum-VT IDE trial

Apr 26, 2026, 9:32 AM EDT - 12 days ago

Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System

Apr 16, 2026, 8:00 AM EDT - 22 days ago

Adagio Medical's ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference

2026-04-14T09:20:20.000Z - 25 days ago

Adagio Medical initiated with an Overweight at Piper Sandler

2026-04-08T12:16:25.000Z - 4 weeks ago

Adagio Medical announces FDA granted IDE approval for FULCRUM-VT trial

Apr 8, 2026, 8:00 AM EDT - 4 weeks ago

Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System

Apr 6, 2026, 8:00 AM EDT - 4 weeks ago

Adagio Medical to Participate in the 25th Annual Needham Virtual Conference

Apr 1, 2026, 8:00 AM EDT - 5 weeks ago

Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026

Mar 27, 2026, 8:00 AM EDT - 6 weeks ago

Adagio Medical Reports Fourth Quarter and Full Year 2025 Results

2026-03-24T12:21:22.000Z - 6 weeks ago

Adagio announces preclinical results for ventricular ablation catheter

Mar 24, 2026, 8:00 AM EDT - 6 weeks ago

Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter

Mar 19, 2026, 8:00 AM EDT - 7 weeks ago

Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS™ System, Including Patients with Premature Ventricular Contractions (PVC)

Mar 11, 2026, 8:00 AM EDT - 2 months ago

Adagio Medical to Participate in the 38th Annual Roth Conference

Feb 20, 2026, 8:00 AM EST - 2 months ago

Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference

2026-02-04T14:20:26.000Z - 3 months ago

Adagio Medical highlights favorable safety profile in cardiac ablation study

Feb 4, 2026, 8:00 AM EST - 3 months ago

New Adagio Medical Publication Highlights Consistent Safety and Effectiveness with Ultralow Temperature Ablation in Broad Range of Patients with Ventricular Tachycardia

Feb 2, 2026, 8:05 AM EST - 3 months ago

Adagio Medical to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Jan 30, 2026, 8:35 AM EST - 3 months ago

Adagio Medical to Present at the Small Cap Growth Virtual Investor Conference February 5th

Dec 22, 2025, 8:00 AM EST - 4 months ago

Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness

Dec 11, 2025, 8:00 AM EST - 5 months ago

Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors

2025-12-02T13:27:19.000Z - 5 months ago

Adagio Medical initiated with a Buy at Lake Street

Nov 12, 2025, 4:05 PM EST - 6 months ago

Adagio Medical Reports Third Quarter 2025 Results

Nov 5, 2025, 8:00 AM EST - 6 months ago

Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference

Oct 20, 2025, 8:00 AM EDT - 7 months ago

Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia

Oct 15, 2025, 8:00 AM EDT - 7 months ago

Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities

2025-10-10T19:45:16.000Z - 7 months ago

Adagio Medical announces preliminary acute results from FULCRUM-VT study

Oct 10, 2025, 3:40 PM EDT - 7 months ago

Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium

2025-10-01T12:15:11.000Z - 7 months ago

Adagio Medical completes enrollment in FULCRUM-VT trial

Oct 1, 2025, 8:00 AM EDT - 7 months ago

Adagio Medical, Inc. Announces Completion of Enrollment for FULCRUM-VT Pivotal Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Ventricular Tachycardia

Sep 18, 2025, 8:00 AM EDT - 8 months ago

Adagio Medical FULCRUM-VT U.S. Pivotal Study Acute Results to be Presented in Late-Breaking Session at VT Symposium

Sep 8, 2025, 8:00 AM EDT - 8 months ago

Adagio Medical Expands Chief Business Officer Deborah Kaster's Role to Include Chief Financial Officer Responsibilities

Aug 13, 2025, 4:30 PM EDT - 9 months ago

Adagio Medical Reports Second Quarter 2025 Results

May 15, 2025, 4:05 PM EDT - 1 year ago

Adagio Medical Reports First Quarter 2025 Results

May 7, 2025, 8:30 AM EDT - 1 year ago

Adagio Medical to Present at the BofA Securities 2025 Health Care Conference

2025-04-17T13:10:54.000Z - 1 year ago

Adagio Medical receives FDA Breakthrough Device designation for vCLAS system

Apr 17, 2025, 8:30 AM EDT - 1 year ago

Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System

2025-03-31T20:05:42.000Z - 1 year ago

Adagio Medical names Deborah Kaster CBO

Mar 31, 2025, 4:01 PM EDT - 1 year ago

Adagio Medical Appoints Deborah Kaster as Chief Business Officer

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Adagio Medical Reports Fourth Quarter and Full Year 2024 Results

Mar 17, 2025, 4:01 PM EDT - 1 year ago

Adagio Medical Provides Clinical and Business Updates

2025-02-28T13:36:12.000Z - 1 year ago

Adagio Medical to reduce workforce in strategic restructuring

Feb 28, 2025, 8:30 AM EST - 1 year ago

Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation

Feb 18, 2025, 4:01 PM EST - 1 year ago

Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference

2024-12-16T13:10:06.000Z - 1 year ago

Adagio Medical CEO Olav Bergheim departs, Todd Usen succeeds

Dec 16, 2024, 8:00 AM EST - 1 year ago

Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director

Nov 14, 2024, 4:01 PM EST - 1 year ago

Adagio Medical Reports Third Quarter 2024 Results

Nov 4, 2024, 4:01 PM EST - 1 year ago

Adagio Medical to Present at the Stifel 2024 Healthcare Conference

2024-10-24T12:51:49.000Z - 1 year ago

Adagio completes first procedures in FULCRUM-VT IDE of VT cryoablation system

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System

Oct 7, 2024, 4:01 PM EDT - 1 year ago

Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias

Aug 19, 2024, 4:01 PM EDT - 1 year ago

Adagio Medical Provides Business Updates

SearchFor911 May. 7 at 11:16 AM

$ADGM very attractive risk/reward here

0 · Reply

BioTuesdays May. 5 at 3:17 PM

1 · Reply

87trades May. 5 at 1:48 PM

$ADGM https://biotuesdays.com/2026/05/05/adagio-delivering-first-of-its-kind-innovation-in-cardiac-ablation-technology/

2 · Reply

zacharyjay4934 May. 4 at 6:57 PM

$ADGM What do we think their intention is around participating?

1 · Reply

VenomSenses May. 2 at 11:52 AM

$ADGM low volume run monday real volume

0 · Reply

PLX_BULLS May. 1 at 12:56 PM

$ADGM Does anyone know the total mean ablation procedure time? Advent trial for pulse field ablation was 106 minutes.

1 · Reply

Rafa007 May. 1 at 11:52 AM

$ADGM teed???????

0 · Reply

PLX_BULLS May. 1 at 3:21 AM

$ADGM What’s their current cash on hand? Do they have a covenant for that 20m in debt?

1 · Reply

slevin_kelevra Apr. 30 at 8:38 PM

$ADGM ugly

0 · Reply

rmccarthy8 Apr. 30 at 12:48 PM

$ADGM why did the stock price plummet after strong data results?!?

2 · Reply

jamescp79 Apr. 29 at 9:12 PM

$ADGM In at 1.12 let's go!

0 · Reply

jamescp79 Apr. 29 at 9:11 PM

$ADGM It wants to run

0 · Reply

Rafa007 Apr. 29 at 5:30 PM

$ADGM 🤕🆘

0 · Reply

zacharyjay4934 Apr. 29 at 12:40 PM

$ADGM https://www.businesswire.com/news/home/20260429404473/en/Adagio-Medical-to-Participate-in-the-BofA-Securities-2026-Health-Care-Conference

0 · Reply

zacharyjay4934 Apr. 29 at 1:49 AM

$ADGM interesting price action AH, up 20% around $1.30, lets see if it holds.

0 · Reply

Maej20 Apr. 28 at 8:10 PM

$ADGM This company's method is to experience modest rises before any positive news, then after the news is released, a vertical drop to the vicinity of the dollar or slightly below it.

2 · Reply

zacharyjay4934 Apr. 28 at 6:09 PM

$ADGM looking for new analyst price targets.

0 · Reply

prismmarketview Apr. 28 at 12:36 PM

(NASDAQ: $ADGM) Adagio Medical plans to use FULCRUM‑VT results to support an FDA PMA filing for its vCLAS ventricular ablation system, potentially adding a new tool for treating drug‑refractory VT. Not investment advice. #FDA #PMA #MedicalDevices #VT #AdagioMedical #ClinicalTrials https://prismmarketview.com/adagio-medicals-fulcrum-vt-trial-delivers-strong-six-month-vt-outcomes/

0 · Reply

Maej20 Apr. 27 at 6:19 PM

$ADGM Whoever controls this stock is undoubtedly foolish. Not gradually raising the stock price with each new development and bringing it back to a price close to a dollar is sheer stupidity. I see some people here talking about the Warrants that Perspective owns at a trading price of 1.71, and I don't see that as a risk. If Perspective is confident in the future of this company, then the only risk from Warrants' is the 7.5 million shares that ATW owns at a trading price I believe is one dollar. Their financing is always toxic, but considering their weak ownership, I think the other shareholders are capable of absorbing it.

1 · Reply

Sisms Apr. 27 at 5:15 PM

$ADGM Short selling fees are getting more expensive Short sellers are trying to force the price down

0 · Reply

Market Cap	21.17M
Revenue (ttm)	0.00
Net Income (ttm)	-25.08M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	1.70

Volume	20,500
Avg Vol	128,728
Day's Range	N/A - N/A
Shares Out	22.21M
Stochastic %K	38%
Beta	-0.14
Analysts	Strong Sell
Price Target	$3.50